Skip to content

The Effect of Exercise on Cognition in Older Adults At-risk for Diabetes: A Feasibility Pilot Study

The Effect of Resistance Training on Cognitive Function and Brain Health in Older Adults At-risk for Diabetes: A Feasibility Pilot Study

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03254381
Enrollment
24
Registered
2017-08-18
Start date
2017-11-02
Completion date
2019-10-03
Last updated
2023-12-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cognitive Impairment

Keywords

cognitive assessment, cognitive function, community dwelling older people, pre-diabetes, randomized control trial, exercise, pilot study, feasibility study

Brief summary

Older adults with type 2 diabetes experience cognitive decline and are at higher risk for developing dementia. Consequently, older adults at-risk for developing type 2 diabetes (based on body mass, glucose levels) are at higher risk for cognitive decline, and intervening at this point may prevent or delay the onset of such decline. One promising lifestyle intervention that has been shown to improve cognitive function in other populations is exercise. However, before investigators can examine whether exercise will improve cognitive function and brain health (structure and function) in this at-risk population, a feasibility pilot study is needed to determine whether a larger-scale trial would be viable.

Detailed description

Investigators will conduct a six-month randomized control trial (RCT) exercise intervention. Thirty older adults (aged 60-80) at-risk for diabetes will be randomly assigned into one of two groups: 1) Resistance training, or 2) Balance and Tone training (control). All participants will engage in three one-hour exercise classes per week. Once a month, a neutral assessor will visit the classes to evaluate the quality of the classes for participants. Assessments will be made at baseline, midpoint (three months) and trial completion (six months), and will include cognitive testing, health questionnaires, physical testing, and magnetic resonance imaging (MRI; to assess structural and functional brain changes). Throughout the study, investigators will examine data for trends in successful recruitment strategies and rates of recruitment and adherence to inform future clinical trials in this population. Research assistants (n = 30) in the study will complete an anonymous feedback survey upon completion of their volunteer term, to assist in improving the study for future participants and volunteers.

Interventions

Six months of thrice-weekly stretching and relaxation exercises. Each session will be 60 minutes. Classes will be group classes, with up to five participants in each.

BEHAVIORALResistance Training

Six months of thrice-weekly resistance training that will gradually progress in intensity. Each training session will be 60 minutes (10 minutes of warm-up, 40 minutes of training, and 10 minutes of cool-down). Classes will be group classes, with up to five participants in each.

Sponsors

Western University, Canada
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
60 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

1\) be community-dwelling 2) be aged 60-80 years 3) be at-risk for diabetes, where they have one of the following: i) blood glucose level of 6.1-7 mmol/L, ii) BMI \> 25, or iii) score \> 21 on the CANRISK diabetes questionnaire 4) score \> 24/30 on MMSE 5) score \> 6/8 on Lawton and Brody's Independent Activities of Daily Living (IADL) scale 6) have visual acuity of at least 20/40, with or without corrective lenses 7) speak and understand English fluently 8) complete the Physical Activity Readiness Questionnaire (PAR-Q) 9) obtain physician's clearance to start a supervised exercise program

Exclusion criteria

1\) have a current medical condition for which exercise is contraindicated 2) have participated regularly in resistance or aerobic training in the last 6 months 3) have been diagnosed with neurodegenerative disease (including dementia, Alzheimer's disease, or Parkinson's disease) 4) have experienced a vascular incident (e.g., stroke, myocardial infarction) 5) have been diagnosed with a psychiatric condition 6) have untreated depression 7) are currently on hormone replacement therapy 8) have clinically significant peripheral neuropathy or severe musculoskeletal or joint disease 9) are currently taking psychotropic medications 10) are unable to participate in MRI (have metal or electronic implants, or are claustrophobic)

Design outcomes

Primary

MeasureTime frame
Number of exercise classes attended at trial completion (6 months)6 months
Number of participants recruited after 12 months12 months

Secondary

MeasureTime frameDescription
Change in hippocampal functional activation as measured during performance on associative memory task during fMRI scanningBaseline and 6 monthsFor this task, participants will be asked to encode and then recall items (face or places) and items in conjunction (faces matched with places)
Change in memory as measured by performance on associative memory taskBaseline, 3 months, and 6 months
Change in executive functions as measured by Stroop TestBaseline, 3 months, and 6 months
Change in cognitive function as measured by Alzheimer's Disease Assessment Scale - Cog - Plus (ADAS-Cog-Plus)Baseline, 3 months, and 6 months
Change in mobility and balance as measured by Short Physical Performance BatteryBaseline, 3 months, and 6 months
Change in muscle strength as measured by one-repetition maximum testBaseline, 3 months, and 6 months
Change in blood glucose levels as measured by finger prick glucose testBaseline, 3 months, and 6 months
Change in aerobic fitness as measured by six minute walk testBaseline, 3 months, and 6 months
Change in hippocampal volume as measured via high resolution T1 images collected during MRI scanning in both 3T and 7T machines.Baseline and 6 months

Countries

Canada

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 20, 2026